Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide
- 1 May 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 180 (2-3) , 297-304
- https://doi.org/10.1016/0014-2999(90)90313-u
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The reversible MAO inhibitor, brofaromine, inhibits serotonin uptake in vivoEuropean Journal of Pharmacology, 1989
- Monoamine Oxidase‐Inhibiting Properties of SR 95191, a New Pyridazine Derivative, in the Rat: Evidence for Selective and Reversible Inhibition of Monoamine Oxidase Type A In Vivo but Not In VitroJournal of Neurochemistry, 1988
- On the reversibility of reversible MAO inhibitorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Reversibility of the interaction of CGP 11305 A with MAO A in vivoEuropean Journal of Pharmacology, 1983
- The monoamine oxidase inhibiting properties of CGP 11305 AEuropean Journal of Pharmacology, 1983
- Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Neurochemical Effects in vitro and in vivo of the Antidepressant Ro 11-1163, a Specific and Short-Acting MAO-A InhibitorPublished by S. Karger AG ,1982